{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:56:46Z","timestamp":1767373006326,"version":"3.37.3"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK110771, DK133392"],"award-info":[{"award-number":["DK110771, DK133392"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11102-024-01421-z","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T07:01:46Z","timestamp":1720162906000},"page":"860-873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of medical therapy for hormone-secreting Pituitary tumors on bone"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1818-0762","authenticated-orcid":false,"given":"Pamela U.","family":"Freda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"1421_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2265.2009.03626.x","volume":"72","author":"TJ Reid","year":"2010","unstructured":"Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006; acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72:203\u2013208","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1421_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000375450","volume":"103","author":"KM Claessen","year":"2016","unstructured":"Claessen KM, Mazziotti G, Biermasz NR, Giustina A (2016) Bone and Joint disorders in Acromegaly. Neuroendocrinology 103(1):86\u201395","journal-title":"Neuroendocrinology"},{"issue":"2","key":"1421_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1530\/EJE-12-0147","volume":"167","author":"KM Claessen","year":"2012","unstructured":"Claessen KM, Ramautar SR, Pereira AM, Smit JW, Roelfsema F, Romijn JA, Kroon HM, Kloppenburg M, Biermasz NR (2012) Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study. Eur J Endocrinol 167(2):235\u2013244","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1421_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/er.2007-0036","volume":"29","author":"A Giustina","year":"2008","unstructured":"Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29(5):535\u2013559","journal-title":"Endocr Rev"},{"issue":"1","key":"1421_CR5","first-page":"55","volume":"19","author":"C Ohlsson","year":"1998","unstructured":"Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19(1):55\u201379","journal-title":"Endocr Rev"},{"issue":"4","key":"1421_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/jcb.22322","volume":"108","author":"E Canalis","year":"2009","unstructured":"Canalis E (2009) Growth factor control of bone mass. J Cell Biochem 108(4):769\u2013777","journal-title":"J Cell Biochem"},{"issue":"4","key":"1421_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jbmr.5650080410","volume":"8","author":"H Kotzmann","year":"1993","unstructured":"Kotzmann H, Bernecker P, Hubsch P, Pietschmann P, Woloszczuk W, Svoboda T, Geyer G, Luger A (1993) Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Min Res 8(4):459\u2013465","journal-title":"J Bone Min Res"},{"issue":"10","key":"1421_CR8","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1359\/jbmr.1997.12.10.1729","volume":"12","author":"A Scillitani","year":"1997","unstructured":"Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, Pileri M, Guglielmi G, Di Giorgio A, Modoni S, Fusilli S, Di Cerbo A, Liuzzi A (1997) Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients. J Bone Min Res 12(10):1729\u20131736","journal-title":"J Bone Min Res"},{"issue":"10","key":"1421_CR9","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1359\/JBMR.050603","volume":"20","author":"S Bonadonna","year":"2005","unstructured":"Bonadonna S, Mazziotti G, Nuzzo M, Bianchi A, Fusco A, De Marinis L, Giustina A (2005) Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J Bone Min Res 20(10):1837\u20131844","journal-title":"J Bone Min Res"},{"issue":"1","key":"1421_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1530\/eje.1.01820","volume":"152","author":"NR Biermasz","year":"2005","unstructured":"Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F (2005) Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly. Eur J Endocrinol 152(1):53\u201360","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1421_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1530\/EJE-08-0449","volume":"159","author":"N Sucunza","year":"2008","unstructured":"Sucunza N, Barahona MJ, Resmini E, Fernandez-Real JM, Farrerons J, Lluch P, Puig T, Wagner AM, Ricart W, Webb SM (2008) Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females. Eur J Endocrinol 159(6):773\u2013779","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1421_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2265.2008.03322.x","volume":"70","author":"C Battista","year":"2009","unstructured":"Battista C, Chiodini I, Muscarella S, Guglielmi G, Mascia ML, Carnevale V, Scillitani A (2009) Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clin Endocrinol (Oxf) 70(3):378\u2013382","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"1421_CR13","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00198-009-1165-x","volume":"21","author":"M Madeira","year":"2010","unstructured":"Madeira M, Neto LV, de Lima GA, Moreira RO, de Mendonca LM, Gadelha MR, Farias ML (2010) Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly. Osteoporos Int 21(12):2019\u20132025","journal-title":"Osteoporos Int"},{"issue":"2","key":"1421_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/EJE-15-0931","volume":"174","author":"E Valassi","year":"2016","unstructured":"Valassi E, Crespo I, Malouf J, Llauger J, Aulinas A, Marin AM, Biagetti B, Webb SM (2016) Reduction of trabecular and cortical volumetric bone mineral density at the proximal femur in patients with acromegaly. Eur J Endocrinol 174(2):107\u2013114","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1421_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s12020-016-1078-3","volume":"54","author":"F Maffezzoni","year":"2016","unstructured":"Maffezzoni F, Maddalo M, Frara S, Mezzone M, Zorza I, Baruffaldi F, Doglietto F, Mazziotti G, Maroldi R, Giustina A (2016) High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures. Endocrine 54(2):532\u2013542","journal-title":"Endocrine"},{"issue":"9","key":"1421_CR16","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1210\/clinem\/dgab260","volume":"106","author":"PPB Silva","year":"2021","unstructured":"Silva PPB, Pereira RMR, Takayama L, Borba CG, Duarte FH, Trarbach EB, Martin RM, Bronstein MD, Tritos NA, Jallad RS (2021) Impaired bone microarchitecture in Premenopausal Women with Acromegaly: the possible role of wnt signaling. J Clin Endocrinol Metab 106(9):2690\u20132706","journal-title":"J Clin Endocrinol Metab"},{"key":"1421_CR17","doi-asserted-by":"publisher","first-page":"738895","DOI":"10.3389\/fendo.2021.738895","volume":"12","author":"L Duan","year":"2021","unstructured":"Duan L, Yang S, Wang LJ, Zhang Y, Li R, Yang H, Zhao Y, Du H, Zhai X, Gong F, Pan H, Zhu H, Xia W (2021) The negative impacts of acromegaly on bone microstructure not fully reversible. Front Endocrinol (Lausanne) 12:738895","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1421_CR18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s12020-021-02751-9","volume":"73","author":"MM Uygur","year":"2021","unstructured":"Uygur MM, Yazici DD, Bugdayci O, Yavuz DG (2021) Prevalence of vertebral fractures and serum sclerostin levels in acromegaly. Endocrine 73(3):667\u2013673","journal-title":"Endocrine"},{"issue":"2","key":"1421_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1530\/EJE-14-0205","volume":"171","author":"M Mormando","year":"2014","unstructured":"Mormando M, Nasto LA, Bianchi A, Mazziotti G, Giampietro A, Pola E, Pontecorvi A, Giustina A, De Marinis L (2014) GH receptor isoforms and skeletal fragility in acromegaly. Eur J Endocrinol 171(2):237\u2013245","journal-title":"Eur J Endocrinol"},{"key":"1421_CR20","doi-asserted-by":"crossref","unstructured":"Nazzari E, Casabella A, Paolino S, Campana C, Corica G, Nista F, Milioto A, Tagliafico A, Albertelli M, Boschetti M, Bagnasco M, Cutolo M, Ferone D, Gatto F (2022) Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients. J Clin Med. ;11(21)","DOI":"10.3390\/jcm11216374"},{"issue":"1","key":"1421_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/cen.14439","volume":"95","author":"M Calatayud","year":"2021","unstructured":"Calatayud M, Perez-Olivares Martin L, Librizzi MS, Lora Pablos D, Gonzalez Mendez V, Aramendi Ramos M, Martinez Diaz-Guerra G, Hawkins F (2021) Trabecular bone score and bone mineral density in patients with long-term controlled acromegaly. Clin Endocrinol (Oxf) 95(1):58\u201364","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1421_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1530\/EJE-18-0881","volume":"180","author":"M Kuzma","year":"2019","unstructured":"Kuzma M, Vanuga P, Sagova I, Pavai D, Jackuliak P, Killinger Z, Binkley NC, Winzenrieth R, Genant HK, Payer J (2019) Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study. Eur J Endocrinol 180(3):201\u2013211","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"1421_CR23","first-page":"1608","volume":"33","author":"PJ Ho","year":"1992","unstructured":"Ho PJ, Fig LM, Barkan AL, Shapiro B (1992) Bone mineral density of the axial skeleton in acromegaly. J Nucl Med 33(9):1608\u20131612","journal-title":"J Nucl Med"},{"issue":"6","key":"1421_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1046\/j.1365-2265.2003.01777.x","volume":"58","author":"A Scillitani","year":"2003","unstructured":"Scillitani A, Battista C, Chiodini I, Carnevale V, Fusilli S, Ciccarelli E, Terzolo M, Oppizzi G, Arosio M, Gasperi M, Arnaldi G, Colao A, Baldelli R, Ghiggi MR, Gaia D, Di Somma C, Trischitta V, Liuzzi A (2003) Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clin Endocrinol (Oxf) 58(6):725\u2013731","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"1421_CR25","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1210\/jc.2008-0791","volume":"93","author":"G Mazziotti","year":"2008","unstructured":"Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L, Giustina A (2008) Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab 93(12):4649\u20134655","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1421_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-0030-1268006","volume":"43","author":"C Jimenez","year":"2011","unstructured":"Jimenez C, Ayala-Ramirez M, Liu J, Nunez R, Gagel RF (2011) Inhibition of growth hormone receptor activation by pegvisomant may increase bone density in acromegaly. Horm Metab Res 43(1):55\u201361","journal-title":"Horm Metab Res"},{"issue":"4","key":"1421_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1530\/EJE-10-1005","volume":"164","author":"MJ Wassenaar","year":"2011","unstructured":"Wassenaar MJ, Biermasz NR, Hamdy NA, Zillikens MC, van Meurs JB, Rivadeneira F, Hofman A, Uitterlinden AG, Stokkel MP, Roelfsema F, Kloppenburg M, Kroon HM, Romijn JA, Pereira AM (2011) High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol 164(4):475\u2013483","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1421_CR28","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1210\/jc.2013-1460","volume":"98","author":"G Mazziotti","year":"2013","unstructured":"Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A, Giampietro A, De Marinis L, Giustina A (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98(8):3402\u20133410","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1421_CR29","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1210\/jc.2013-2695","volume":"98","author":"KM Claessen","year":"2013","unstructured":"Claessen KM, Kroon HM, Pereira AM, Appelman-Dijkstra NM, Verstegen MJ, Kloppenburg M, Hamdy NA, Biermasz NR (2013) Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study. J Clin Endocrinol Metab 98(12):4808\u20134815","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1421_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/EJE-16-0340","volume":"175","author":"K Godang","year":"2016","unstructured":"Godang K, Olarescu NC, Bollerslev J, Heck A (2016) Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study. Eur J Endocrinol 175(2):155\u2013164","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1421_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12020-017-1391-5","volume":"59","author":"S Chiloiro","year":"2018","unstructured":"Chiloiro S, Mormando M, Bianchi A, Giampietro A, Milardi D, Bima C, Grande G, Formenti AM, Mazziotti G, Pontecorvi A, Giustina A, De Marinis L (2018) Prevalence of morphometric vertebral fractures in difficult patients with acromegaly with different biochemical outcomes after multimodal treatment. Endocrine 59(2):449\u2013453","journal-title":"Endocrine"},{"issue":"3","key":"1421_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11102-018-0873-7","volume":"21","author":"S Chiloiro","year":"2018","unstructured":"Chiloiro S, Mazziotti G, Giampietro A, Bianchi A, Frara S, Mormando M, Pontecorvi A, Giustina A, De Marinis L (2018) Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. Pituitary 21(3):302\u2013308","journal-title":"Pituitary"},{"issue":"1","key":"1421_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11102-017-0847-1","volume":"21","author":"L Dalle Carbonare","year":"2018","unstructured":"Dalle Carbonare L, Micheletti V, Cosaro E, Valenti MT, Mottes M, Francia G, Davi MV (2018) Bone histomorphometry in acromegaly patients with fragility vertebral fractures. Pituitary 21(1):56\u201364","journal-title":"Pituitary"},{"issue":"4","key":"1421_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1530\/EJE-20-0415","volume":"183","author":"ICM Pelsma","year":"2020","unstructured":"Pelsma ICM, Biermasz NR, Pereira AM, van Furth WR, Appelman-Dijkstra NM, Kloppenburg M, Kroon HM, Claessen K (2020) Progression of vertebral fractures in long-term controlled acromegaly: a 9-year follow-up study. Eur J Endocrinol 183(4):427\u2013437","journal-title":"Eur J Endocrinol"},{"key":"1421_CR35","doi-asserted-by":"crossref","unstructured":"Chiloiro S, Giampietro A, Frara S, Bima C, Donfrancesco F, Fleseriu CM, Pontecorvi A, Giustina A, Fleseriu M, De Marinis L, Bianchi A (2020) Effects of Pegvisomant and Pasireotide LAR on Vertebral fractures in Acromegaly resistant to first-generation SRLs. J Clin Endocrinol Metab. ;105(3)","DOI":"10.1210\/clinem\/dgz054"},{"issue":"8","key":"1421_CR36","doi-asserted-by":"publisher","first-page":"bvab090","DOI":"10.1210\/jendso\/bvab090","volume":"5","author":"E Sala","year":"2021","unstructured":"Sala E, Malchiodi E, Carosi G, Verrua E, Cairoli E, Ferrante E, Filopanti M, Eller-Vainicher C, Ulivieri FM, Spada A, Arosio M, Chiodini I, Mantovani G (2021) Spine bone texture assessed by trabecular bone score in active and controlled acromegaly: a prospective study. J Endocr Soc 5(8):bvab090","journal-title":"J Endocr Soc"},{"issue":"10","key":"1421_CR37","doi-asserted-by":"publisher","first-page":"bvad121","DOI":"10.1210\/jendso\/bvad121","volume":"7","author":"AP Kuker","year":"2023","unstructured":"Kuker AP, Agarwal S, Shane E, Cohen A, Nickolas TL, Stein EM, Reid TJ, Hans D, Cremers S, Bruce JN, Freda PU (2023) Persistent deficits in bone quality in treated acromegaly: evidence from assessments of microstructure. J Endocr Soc 7(10):bvad121","journal-title":"J Endocr Soc"},{"issue":"6","key":"1421_CR38","doi-asserted-by":"publisher","first-page":"bvae079","DOI":"10.1210\/jendso\/bvae079","volume":"8","author":"AP Kuker","year":"2024","unstructured":"Kuker AP, Agarwal S, Shane E, Bicca J, Geer EB, Cremers S, Dworakowski E, Cohen A, Nickolas TL, Stein EM, Freda PU (2024) Long-term Pegvisomant Therapy of Acromegaly: effects on bone density, turnover and microstructure using HRpQCT. J Endocr Soc 8(6):bvae079","journal-title":"J Endocr Soc"},{"issue":"3","key":"1421_CR39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/BF00298716","volume":"52","author":"M Terzolo","year":"1993","unstructured":"Terzolo M, Piovesan A, Osella G, Pia A, Reimondo G, Pozzi C, Raucci C, Torta M, Paccotti P, Angeli A (1993) Serum levels of bone gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment. Calcif Tissue Int 52(3):188\u2013191","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"1421_CR40","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1210\/jc.2016-3693","volume":"102","author":"T Constantin","year":"2017","unstructured":"Constantin T, Tangpricha V, Shah R, Oyesiku NM, Ioachimescu OC, Ritchie J, Ioachimescu AG (2017) Calcium and bone turnover markers in Acromegaly: a prospective, controlled study. J Clin Endocrinol Metab 102(7):2416\u20132424","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1421_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1507\/endocrj.EJ13-0387","volume":"61","author":"D Tamada","year":"2014","unstructured":"Tamada D, Kitamura T, Onodera T, Tabuchi Y, Fukuhara A, Oshino S, Saitoh Y, Hamasaki T, Otsuki M, Shimomura I (2014) Rapid decline in bone turnover markers but not bone mineral density in acromegalic patients after transsphenoidal surgery. Endocr J 61(3):231\u2013237","journal-title":"Endocr J"},{"issue":"1","key":"1421_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2265.1998.00349.x","volume":"48","author":"GP Lesse","year":"1998","unstructured":"Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP (1998) Gonadal status is an important determinant of bone density in acromegaly. Clin Endocrinol (Oxf) 48(1):59\u201365","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1421_CR43","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s11102-022-01256-6","volume":"25","author":"C Ribeiro de Moura","year":"2022","unstructured":"Ribeiro de Moura C, Campos Lopes S, Monteiro AM (2022) Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis. Pituitary 25(6):780\u2013794","journal-title":"Pituitary"},{"issue":"2","key":"1421_CR44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1210\/jc.2014-2937","volume":"100","author":"G Mazziotti","year":"2015","unstructured":"Mazziotti G, Biagioli E, Maffezzoni F, Spinello M, Serra V, Maroldi R, Floriani I, Giustina A (2015) Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab 100(2):384\u2013394","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1421_CR45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.1365-2265.2002.01624.x","volume":"57","author":"WP Fairfield","year":"2002","unstructured":"Fairfield WP, Sesmilo G, Katznelson L, Pulaski K, Freda PU, Stavrou S, Kleinberg D, Klibanski A (2002) Effects of a growth hormone receptor antagonist on bone markers in acromegaly. Clin Endocrinol (Oxf) 57(3):385\u2013390","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"1421_CR46","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1210\/jc.2003-030772","volume":"88","author":"C Parkinson","year":"2003","unstructured":"Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ (2003) Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal. J Clin Endocrinol Metab 88(12):5650\u20135655","journal-title":"J Clin Endocrinol Metab"},{"key":"1421_CR47","doi-asserted-by":"crossref","unstructured":"Vitali E, Grasso A, Schiavone ML, Trivellin G, Sobacchi C, Mione M, Mazziotti G, Lania A (2023) The direct impact of pegvisomant on osteoblast functions and bone development. J Endocrinol Invest","DOI":"10.1007\/s40618-023-02281-3"},{"key":"1421_CR48","doi-asserted-by":"crossref","unstructured":"Sorohan MC, Poiana C (2022) Vertebral fractures in Acromegaly: a systematic review. J Clin Med. ;12(1)","DOI":"10.3390\/jcm12010164"},{"issue":"1","key":"1421_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00198-012-2188-2","volume":"24","author":"S Boutroy","year":"2013","unstructured":"Boutroy S, Hans D, Sornay-Rendu E, Vilayphiou N, Winzenrieth R, Chapurlat R (2013) Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study. Osteoporos Int 24(1):77\u201385","journal-title":"Osteoporos Int"},{"issue":"3","key":"1421_CR50","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jocd.2013.01.006","volume":"16","author":"WD Leslie","year":"2013","unstructured":"Leslie WD, Krieg MA, Hans D, Manitoba Bone Density P (2013) Clinical factors associated with trabecular bone score. J Clin Densitom 16(3):374\u2013379","journal-title":"J Clin Densitom"},{"issue":"3","key":"1421_CR51","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00198-015-3344-2","volume":"27","author":"AR Hong","year":"2016","unstructured":"Hong AR, Kim JH, Kim SW, Kim SY, Shin CS (2016) Trabecular bone score as a skeletal fragility index in acromegaly patients. Osteoporos Int 27(3):1123\u20131129","journal-title":"Osteoporos Int"},{"issue":"1","key":"1421_CR52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11657-021-00986-7","volume":"16","author":"MC Sorohan","year":"2021","unstructured":"Sorohan MC, Dusceac R, Sorohan BM, Caragheorgheopol A, Poiana C (2021) Trabecular bone score and bone mineral density in acromegalic osteopathy assessment: a cross-sectional study. Arch Osteoporos 16(1):134","journal-title":"Arch Osteoporos"},{"issue":"4","key":"1421_CR53","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000528199","volume":"113","author":"F Bioletto","year":"2023","unstructured":"Bioletto F, Barale M, Prencipe N, Berton AM, Parasiliti-Caprino M, Gasco V, Ghigo E, Procopio M, Grottoli S (2023) Trabecular bone score as an index of bone fragility in patients with acromegaly: a systematic review and Meta-analysis. Neuroendocrinology 113(4):395\u2013405","journal-title":"Neuroendocrinology"},{"issue":"12","key":"1421_CR54","first-page":"e5088","volume":"106","author":"M Kuzma","year":"2021","unstructured":"Kuzma M, Vanuga P, Sagova I, Pavai D, Jackuliak P, Killinger Z, Binkley N, Winzenrieth R, Payer J (2021) Vertebral fractures occur despite control of Acromegaly and are predicted by cortical volumetric bone Mineral Density. J Clin Endocrinol Metab 106(12):e5088\u2013e5096","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1421_CR55","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1359\/jbmr.061206","volume":"22","author":"E Sornay-Rendu","year":"2007","unstructured":"Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD (2007) Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Min Res 22(3):425\u2013433","journal-title":"J Bone Min Res"},{"issue":"2","key":"1421_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/jbmr.562","volume":"27","author":"XS Liu","year":"2012","unstructured":"Liu XS, Stein EM, Zhou B, Zhang CA, Nickolas TL, Cohen A, Thomas V, McMahon DJ, Cosman F, Nieves J, Shane E, Guo XE (2012) Individual trabecula segmentation (ITS)-based morphological analyses and microfinite element analysis of HR-pQCT images discriminate postmenopausal fragility fractures independent of DXA measurements. J Bone Min Res 27(2):263\u2013272","journal-title":"J Bone Min Res"},{"issue":"12","key":"1421_CR57","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1002\/jbmr.152","volume":"25","author":"EM Stein","year":"2010","unstructured":"Stein EM, Liu XS, Nickolas TL, Cohen A, Thomas V, McMahon DJ, Zhang C, Yin PT, Cosman F, Nieves J, Guo XE, Shane E (2010) Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Min Res 25(12):2572\u20132581","journal-title":"J Bone Min Res"},{"issue":"6","key":"1421_CR58","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/jbmr.2796","volume":"31","author":"S Boutroy","year":"2016","unstructured":"Boutroy S, Khosla S, Sornay-Rendu E, Zanchetta MB, McMahon DJ, Zhang CA, Chapurlat RD, Zanchetta J, Stein EM, Bogado C, Majumdar S, Burghardt AJ, Shane E (2016) Microarchitecture and peripheral BMD are impaired in Postmenopausal White Women with fracture independently of total hip T-Score: an International Multicenter Study. J Bone Min Res 31(6):1158\u20131166","journal-title":"J Bone Min Res"},{"issue":"2","key":"1421_CR59","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/jbmr.3299","volume":"33","author":"E Biver","year":"2018","unstructured":"Biver E, Durosier-Izart C, Chevalley T, van Rietbergen B, Rizzoli R, Ferrari S (2018) Evaluation of Radius microstructure and areal bone Mineral Density improves fracture prediction in Postmenopausal Women. J Bone Min Res 33(2):328\u2013337","journal-title":"J Bone Min Res"},{"issue":"4","key":"1421_CR60","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1210\/jc.2012-4073","volume":"98","author":"M Madeira","year":"2013","unstructured":"Madeira M, Neto LV, de Paula Paranhos Neto F, Barbosa Lima IC, Carvalho de Mendonca LM, Gadelha MR, Fleiuss de Farias ML (2013) Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 98(4):1734\u20131741","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1421_CR61","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/EJE-17-0468","volume":"177","author":"PPB Silva","year":"2017","unstructured":"Silva PPB, Amlashi FG, Yu EW, Pulaski-Liebert KJ, Gerweck AV, Fazeli PK, Lawson E, Nachtigall LB, Biller BMK, Miller KK, Klibanski A, Bouxsein M, Tritos NA (2017) Bone microarchitecture and estimated bone strength in men with active acromegaly. Eur J Endocrinol 177(5):409\u2013420","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1421_CR62","doi-asserted-by":"publisher","first-page":"e2843","DOI":"10.1210\/clinem\/dgac183","volume":"107","author":"S Frara","year":"2022","unstructured":"Frara S, Melin Uygur M, di Filippo L, Doga M, Losa M, Santoro S, Mortini P, Giustina A (2022) High prevalence of vertebral fractures Associated with preoperative GH levels in patients with recent diagnosis of Acromegaly. J Clin Endocrinol Metab 107(7):e2843\u2013e2850","journal-title":"J Clin Endocrinol Metab"},{"key":"1421_CR63","doi-asserted-by":"crossref","unstructured":"Mazziotti G, Battista C, Maffezzoni F, Chiloiro S, Ferrante E, Prencipe N, Grasso L, Gatto F, Olivetti R, Arosio M, Barale M, Bianchi A, Cellini M, Chiodini I, De Marinis L, Del Sindaco G, Di Somma C, Ferlin A, Ghigo E, Giampietro A, Grottoli S, Lavezzi E, Mantovani G, Morenghi E, Pivonello R, Porcelli T, Procopio M, Pugliese F, Scillitani A, Lania AG (2020) Treatment of Acromegalic Osteopathy in Real-life clinical practice: the BAAC (bone active drugs in acromegaly) study. J Clin Endocrinol Metab. ;105(9)","DOI":"10.1210\/clinem\/dgaa363"},{"issue":"26","key":"1421_CR64","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJM198012253032605","volume":"303","author":"A Klibanski","year":"1980","unstructured":"Klibanski A, Neer RM, Beitins IZ, Ridgway EC, Zervas NT, McArthur JW (1980) Decreased bone density in hyperprolactinemic women. N Engl J Med 303(26):1511\u20131514","journal-title":"N Engl J Med"},{"issue":"1","key":"1421_CR65","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1210\/jcem-67-1-124","volume":"67","author":"A Klibanski","year":"1988","unstructured":"Klibanski A, Biller BM, Rosenthal DI, Schoenfeld DA, Saxe V (1988) Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab 67(1):124\u2013130","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1421_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12020-014-0308-9","volume":"48","author":"AT Faje","year":"2015","unstructured":"Faje AT, Klibanski A (2015) The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: cons. Endocrine 48(1):79\u201382","journal-title":"Endocrine"},{"issue":"3","key":"1421_CR67","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1365-2265.2000.00902.x","volume":"52","author":"A Colao","year":"2000","unstructured":"Colao A, Di Somma C, Loche S, Di Sarno A, Klain M, Pivonello R, Pietrosante M, Salvatore M, Lombardi G (2000) Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clin Endocrinol (Oxf) 52(3):319\u2013327","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1421_CR68","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1210\/jcem.83.3.4674","volume":"83","author":"C Di Somma","year":"1998","unstructured":"Di Somma C, Colao A, Di Sarno A, Klain M, Landi ML, Facciolli G, Pivonello R, Panza N, Salvatore M, Lombardi G (1998) Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. J Clin Endocrinol Metab 83(3):807\u2013813","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1421_CR69","first-page":"692","volume":"75","author":"BM Biller","year":"1992","unstructured":"Biller BM, Baum HB, Rosenthal DI, Saxe VC, Charpie PM, Klibanski A (1992) Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 75(3):692\u2013697","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1421_CR70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11102-007-0064-4","volume":"11","author":"EC Naliato","year":"2008","unstructured":"Naliato EC, Violante AH, Caldas D, Farias ML, Bussade I, Lamounier Filho A, Loureiro CR, Fontes R, Schrank Y, Loures T, Colao A (2008) Bone density in women with prolactinoma treated with dopamine agonists. Pituitary 11(1):21\u201328","journal-title":"Pituitary"},{"issue":"8","key":"1421_CR71","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3109\/09513591003686320","volume":"26","author":"M Bolanowski","year":"2010","unstructured":"Bolanowski M, Zadrozna-Sliwka B, Jawiarczyk A, Syrycka J (2010) The influence of other than prolactin hormones on bone mineral density in women with hyperprolactinaemia of various origins. Gynecol Endocrinol 26(8):623\u2013627","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"1421_CR72","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00198-021-06289-4","volume":"33","author":"L Wang","year":"2022","unstructured":"Wang L, Chen K, Duan L, Ke X, Gong F, Pan H, Yang H, Zhu H, Xia W (2022) Bone microarchitecture impairment in prolactinoma patients assessed by HR-pQCT. Osteoporos Int 33(7):1535\u20131544","journal-title":"Osteoporos Int"},{"issue":"3","key":"1421_CR73","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.bone.2007.11.008","volume":"42","author":"D Seriwatanachai","year":"2008","unstructured":"Seriwatanachai D, Thongchote K, Charoenphandhu N, Pandaranandaka J, Tudpor K, Teerapornpuntakit J, Suthiphongchai T, Krishnamra N (2008) Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand\/osteoprotegerin ratio. Bone 42(3):535\u2013546","journal-title":"Bone"},{"issue":"4","key":"1421_CR74","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jcb.22161","volume":"107","author":"D Seriwatanachai","year":"2009","unstructured":"Seriwatanachai D, Krishnamra N, van Leeuwen JP (2009) Evidence for direct effects of prolactin on human osteoblasts: inhibition of cell growth and mineralization. J Cell Biochem 107(4):677\u2013685","journal-title":"J Cell Biochem"},{"issue":"6","key":"1421_CR75","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1210\/jcem-56-6-1120","volume":"56","author":"JA Schlechte","year":"1983","unstructured":"Schlechte JA, Sherman B, Martin R (1983) Bone density in amenorrheic women with and without hyperprolactinemia. J Clin Endocrinol Metab 56(6):1120\u20131123","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1421_CR76","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1210\/jcem-64-5-1021","volume":"64","author":"J Schlechte","year":"1987","unstructured":"Schlechte J, el-Khoury G, Kathol M, Walkner L (1987) Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 64(5):1021\u20131026","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1421_CR77","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/BF02554932","volume":"37","author":"MP Caraceni","year":"1985","unstructured":"Caraceni MP, Corghi E, Ortolani S, Casazza S, D\u2019Alberton A, Motta T (1985) Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia. Calcif Tissue Int 37(6):687\u2013689","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"1421_CR78","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJM198608283150903","volume":"315","author":"A Klibanski","year":"1986","unstructured":"Klibanski A, Greenspan SL (1986) Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med 315(9):542\u2013546","journal-title":"N Engl J Med"},{"issue":"6","key":"1421_CR79","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/0003-4819-104-6-777","volume":"104","author":"SL Greenspan","year":"1986","unstructured":"Greenspan SL, Neer RM, Ridgway EC, Klibanski A (1986) Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 104(6):777\u2013782","journal-title":"Ann Intern Med"},{"issue":"7","key":"1421_CR80","doi-asserted-by":"publisher","first-page":"526","DOI":"10.7326\/0003-4819-110-7-526","volume":"110","author":"SL Greenspan","year":"1989","unstructured":"Greenspan SL, Oppenheim DS, Klibanski A (1989) Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110(7):526\u2013531","journal-title":"Ann Intern Med"},{"issue":"5","key":"1421_CR81","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/BF03350694","volume":"13","author":"A Sartorio","year":"1990","unstructured":"Sartorio A, Conti A, Ambrosi B, Muratori M, Morabito F, Faglia G (1990) Osteocalcin levels in patients with microprolactinoma before and during medical treatment. J Endocrinol Invest 13(5):419\u2013422","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1421_CR82","first-page":"423","volume":"128","author":"O Torring","year":"1993","unstructured":"Torring O, Isberg B, Sjoberg HE, Bucht E, Hulting AL (1993) Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment. Acta Endocrinol (Copenh) 128(5):423\u2013427","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"2","key":"1421_CR83","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.0300-0664.2001.01464.x","volume":"56","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Jorgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Weeke J, Andersen M, Conceicao FL, Nielsen TL, Mosekilde L (2002) Fracture risk is increased in patients with GH deficiency or untreated prolactinomas\u2013a case-control study. Clin Endocrinol (Oxf) 56(2):159\u2013167","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1421_CR84","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11102-011-0293-4","volume":"14","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Mancini T, Mormando M, De Menis E, Bianchi A, Doga M, Porcelli T, Vescovi PP, De Marinis L, Giustina A (2011) High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary 14(4):299\u2013306","journal-title":"Pituitary"},{"issue":"3","key":"1421_CR85","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12020-011-9462-5","volume":"39","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Porcelli T, Mormando M, De Menis E, Bianchi A, Mejia C, Mancini T, De Marinis L, Giustina A (2011) Vertebral fractures in males with prolactinoma. Endocrine 39(3):288\u2013293","journal-title":"Endocrine"},{"key":"1421_CR86","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.wneu.2016.10.059","volume":"97","author":"L Andereggen","year":"2017","unstructured":"Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW, Christ E (2017) Long-term Follow-Up of Primary Medical Versus Surgical treatment of Prolactinomas in men: effects on Hyperprolactinemia, Hypogonadism, and Bone Health. World Neurosurg 97:595\u2013602","journal-title":"World Neurosurg"},{"issue":"1","key":"1421_CR87","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1038\/s41598-021-84606-x","volume":"11","author":"L Andereggen","year":"2021","unstructured":"Andereggen L, Frey J, Andres RH, Luedi MM, Widmer HR, Beck J, Mariani L, Christ E (2021) Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas. Sci Rep 11(1):5122","journal-title":"Sci Rep"},{"issue":"8","key":"1421_CR88","first-page":"745","volume":"36","author":"C D\u2019Sylva","year":"2015","unstructured":"D\u2019Sylva C, Khan T, Van Uum S, Fraser LA (2015) Osteoporotic fractures in patients with untreated hyperprolactinemia vs. those taking dopamine agonists: a systematic review and meta-analysis. Neuro Endocrinol Lett 36(8):745\u2013749","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"1421_CR89","doi-asserted-by":"publisher","first-page":"101515","DOI":"10.1016\/j.beem.2021.101515","volume":"35","author":"S Frara","year":"2021","unstructured":"Frara S, Allora A, di Filippo L, Formenti AM, Loli P, Polizzi E, Tradati D, Ulivieri FM, Giustina A (2021) Osteopathy in mild adrenal Cushing\u2019s syndrome and Cushing disease. Best Pract Res Clin Endocrinol Metab 35(2):101515","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"1421_CR90","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1530\/eje.0.1460051","volume":"146","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Lindholm J, Jorgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Kristensen LO, Feldt-Rasmussen U, Mosekilde L (2002) Increased risk of osteoporotic fractures in patients with Cushing\u2019s syndrome. Eur J Endocrinol 146(1):51\u201356","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1421_CR91","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1046\/j.1365-2265.2003.01713.x","volume":"58","author":"C Di Somma","year":"2003","unstructured":"Di Somma C, Pivonello R, Loche S, Faggiano A, Klain M, Salvatore M, Lombardi G, Colao A (2003) Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing\u2019s disease: a prospective study. Clin Endocrinol (Oxf) 58(3):302\u2013308","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1421_CR92","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11102-011-0306-3","volume":"15","author":"ME Randazzo","year":"2012","unstructured":"Randazzo ME, Grossrubatscher E, Dalino Ciaramella P, Vanzulli A, Loli P (2012) Spontaneous recovery of bone mass after cure of endogenous hypercortisolism. Pituitary 15(2):193\u2013201","journal-title":"Pituitary"},{"issue":"2","key":"1421_CR93","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12020-023-03318-6","volume":"80","author":"F Ferrau","year":"2023","unstructured":"Ferrau F, Giovinazzo S, Alessi Y, Catalano A, Tessitore A, Mormina E, Bellone F, Giuffrida G, Paola G, Cotta OR, Ragonese M, Granata F, Lania AG, Mazziotti G, Cannavo S (2023) Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome. Endocrine 80(2):441\u2013447","journal-title":"Endocrine"},{"issue":"4","key":"1421_CR94","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tem.2023.01.006","volume":"34","author":"MM Uygur","year":"2023","unstructured":"Uygur MM, Frara S, di Filippo L, Giustina A (2023) New tools for bone health assessment in secreting pituitary adenomas. Trends Endocrinol Metab 34(4):231\u2013242","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"1421_CR95","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s001980170025","volume":"12","author":"G Luisetto","year":"2001","unstructured":"Luisetto G, Zangari M, Camozzi V, Boscaro M, Sonino N, Fallo F (2001) Recovery of bone mineral density after surgical cure, but not by ketoconazole treatment, in Cushing\u2019s syndrome. Osteoporos Int 12(11):956\u2013960","journal-title":"Osteoporos Int"},{"issue":"1","key":"1421_CR96","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1530\/EJE-07-0514","volume":"158","author":"F Castinetti","year":"2008","unstructured":"Castinetti F, Morange I, Jaquet P, Conte-Devolx B, Brue T (2008) Ketoconazole revisited: a preoperative or postoperative treatment in Cushing\u2019s disease. Eur J Endocrinol 158(1):91\u201399","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01421-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01421-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01421-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T06:18:34Z","timestamp":1733897914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01421-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1421"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01421-z","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"type":"print","value":"1386-341X"},{"type":"electronic","value":"1573-7403"}],"subject":[],"published":{"date-parts":[[2024,7,5]]},"assertion":[{"value":"22 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}